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Objective(s): In this study, the neutralizing abilities of the equine and the recently introduced camelid 
antivenoms on the hemodynamic parameters (inotropism, chronotropism, and arrhythmogenicity) 
were assessed following envenomation by Hemiscorpius lepturus venom in rats. 
Materials and Methods: At first, the electrophoretic profiles of both products were obtained by using the 
SDS-PAGE method (12.5%) and stained with Coomassie blue and silver nitrate. Secondly, different doses of 
the camelid antivenom (10, 50, and 100 µl) were given intravenously in 10 min before venom injection (400 
µg/rat). The neutralizing potencies of camelid and equine antivenoms were measured by preincubation 
(100 µl) with H. lepturus venom for 30 min at room temperature. Finally, equal amounts of the antivenoms 
were injected intravenously to observe the hemodynamic changes.
Results: Based on the electrophoretic profile, it was evident that undesired proteins significantly 
decreased in equine antivenom, owing to impurities. Pretreatment with the camelid antivenom (100 
µl), neutralized the elevation of the mean arterial pressure evoked with scorpion venom injection 
(88.15±4.56 versus 10.2±1.23 percent at the 8th min). The Incubation of the venom and the camelid 
antivenom counteracted the hemodynamic changes, but the equine product had no effect. The 
intravascular injection of the equine antivenom transiently increased the mean arterial pressure as 
compared to the control (108.67±8.63 mmHg versus 52.67±1.93 mmHg at the 10th min).
Conclusion: The most obvious finding emerging from this study was that the camelid antivenom 
neutralized the hemodynamic changes in rats significantly, but in comparison, the equine antivenom 
had just a minor ability.
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Introduction
Scorpion sting as the oldest arthropod (20 families, 
208 genera, and 2231 species) (1) is common in the 
tropical and subtropical areas of the world, including 
Iran, especially in south-western regions (2). To date, 
various research has tended to reveal many detrimental 
cardiovascular changes including hypertension, 
pulmonary edema, and arrhythmia in the animals due to 
envenomation (3, 4). In this regard, a strong relationship 
has been found between the initial stimulatory effects 
of the venom on the autonomic nervous system and the 
subsequent cardiac changes (4).
It is known that Hemiscorpius lepturus is one of the 
most dangerous scorpions in Iran (5). In most cases, 
the clinical symptoms of the envenomed patients 
(hematuria, cardiovascular deteriorations, and dermal 
lesions) are not serious, while in a minority of cases, 
especially in infants, it will lead to renal tubular necrosis 
and death due to hemolytic uremic syndrome (6). 
The treatment of scorpion sting needs symptomatic 
therapy and the injection of equine polyvalent antivenom, 
which has been produced against six dangerous Iranian 
scorpions. There is controversy over the effectiveness 
of the conventional equine antivenom since Fab and 
F (ab′)2 products reach the vital organs 5 to 9 times 
later following the venom exposure because of their 
large sizes (7, 8). Moreover, early or late anaphylactic 
reactions may be observed in victims (9%) treated 
with the medication (9). However, camelid antivenom 
has been introduced recently as a novel serum therapy 
against snake and scorpion envenomations due to its 
unique properties. Furthermore, the absence of the 
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light chains and the first part of the heavy chain in the 
serum of this animal makes it more compatible with 
humans. Besides, the adverse anaphylactic reactions 
are reduced due to the compatibility of its Ig G content 
(10). Therefore, this experimental animal study set 
out to compare the neutralizing effects of the camelid 
and equine antivenoms upon transient hypertension 
and bradycardia caused by the venom. Ultimately, it 
evaluates the hemodynamic changes induced by their 
own injections (11).
Materials and Methods
Venom and antivenom preparation
H. lepturus crude venom and the equine antivenom 
were obtained from Razi Institute of Iran (Karaj 
province). The precipitated camelid antivenom with 
saturated ammonium sulfate (SAS) was taken from 
Iranian Pasteur Institute following immunization of 
young camels with H. lepturus venom (12).
In this case, raw venoms were milked by applying 
direct electrical shock (15 V) to their telsons. The 
collected venom was transferred to a microcentrifuge 
tube, lyophilized, and stored at -20 °C following 
centrifugation at 1000 rpm for 20 min. The polyvalent 
antivenoms (5 ml ampoules), were used in our study. 
SDS-PAGE
At first, the protein concentrations of our samples 
were measured by the Bradford method with bovine 
serum albumin as the control (13). Secondly, the camelid 
and equine antivenom samples were heated at 95 °C for 
5 min and then cooled on ice. The protein components 
of both products were analyzed using SDS-PAGE with 
12.5 % gels according to the Laemmli method. Gels were 
stained with Coomassie blue R-250 and silver nitrate to 
visualize the protein bands. Protein quantitation was 
achieved using a prestained protein ladder (CSL-BBL 
Cleaver company), ranging from 11-245 kDa. 
Experimental protocol
Male Wistar rats (250–300 g) were housed in 
polycarbonate cages with free access to water and 
chow in the animal house of Bushehr University of 
Medical Sciences for one week before our study. They 
were anesthetized with ketamine (100 mg/kg, IP) and 
xylazine (10 mg/kg, IP) before the experiment.
The anesthetized rats were placed supine under a 
heat lamp, and their temperature was monitored with 
a rectal tube connected to a thermometer (Physitemp 
BAT-12, Texas Scientific Instruments, San Antonio, Texas, 
USA). An incision was made in the right femoral area, 
and two cannulas were inserted in the femoral artery 
and vein, in order to administer the venom/antivenom 
and measure hemodynamic changes (arterial pressure, 
heart rate, and arrhythmia). Our data were analyzed 
using a pressure transducer (MLT844, AD Instruments, 
Australia) for a sustained recording of the arterial 
pressure by means of a Power Lab/4SP data acquisition 
system (AD Instruments). Final results were obtained 
20 min after the beginning of the experiments following 
the administration of the venom or antivenoms. Mean 
arterial pressure was calculated using the following 
formula:  [(2 x diastolic) + systolic] divided by 3.
Antivenom effects
Three groups of rats (six animals each) were 
pretreated with different doses of the camelid antivenom 
(10, 50, and 100 µl in a dose of 200 µl of saline) slowly 
ten min before the venom injection (400 µg/rat) (11). 
The last group was treated with normal saline, and the 
study was continued. In another set of our experiments, 
two doses of the camelid and equine antivenoms (100 µl) 
were mixed with the venom and incubated half an hour 
at room temperature. The hemodynamic parameters 
(inotropism, chronotropism, and arrhythmogenicity) 
were measured following the intravenous injection of 
the cocktail.
The effects of the camelid and equine antivenoms on 
hemodynamic parameters
The animals were divided into three groups (n=6), 
and the cardiac parameters were measured 20 min 
before the antivenin medications. Normal saline 
(200 µl) was injected in the first group as a negative 
control. The camelid and equine antivenoms with the 
same volume were infused via the femoral vein in two 
minutes. Inotropic, chronotropic, and arrhythmogenic 
parameters were evaluated in the last two groups and 
compared with the former. 
Statistical analysis
Results were expressed as mean±SD (standard 
deviation of the mean) and were evaluated using one- 
or two-way analysis of variance (ANOVA) followed by 
Tukey’s post hoc test. Results were also analyzed by 
Student’s t-test. In all cases, differences were considered 
significant at P-value<0.05
Results
Gel electrophoresis
The electrophoretic profiles of the camelid and 
conventional antivenoms showed at least 7 and 3 bands 
in Coomassie blue staining distributed between 11-260 
kDa (Figure 1A). The major bands of these two products 
were located at 59, 46, 36, 32, 18, and 14 kDa and 61, 33, 
and 19 kDa, respectively. The other protein bands were 
revealed after silver nitrate staining in both products 
(Figure 1B). 
 
  
Figure 1. SDS- PAGE analysis of the camelid and equine antivenoms. 
Lanes 1 and 2 are the equine antivenoms, while lanes 3 and 4 are the 
camelids in Coomassie (A) and silver nitrate staining (B). M is the 
protein marker ranging from 11-245 kDa
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Neutralizing effects of the camelid antivenom
The scorpion venom evoked transient hypertensive 
effects considerably, and it reached the maximum level 
of 88.15% increase in mean arterial pressure (MAP) in 
eight minutes (Figure 2). The prior instillation of the 
camelid antivenom (100 µl) significantly reduced this 
property (10.24 versus 88.15 percent). This volume was 
selected for our later experiments. 
Hemodynamic potencies of the camelid and equine 
antivenoms 
Injection of the camelid and equine antivenoms (100 
µl/rat; IV) in separate experiments caused different 
inotropic, chronotropic, and arrhythmogenic properties 
among the anesthetized rats. There was no increase 
in MAP within 20 min after the camelid antivenom 
injection as compared to normal saline (Table 1), while 
it stands out that there was a significant difference in 
MAP between the equine and control during this time. 
Despite the significant bradycardia caused by the equine 
injection, there were no alterations in the camelid 
product (data not shown). According to Figure 3, there 
was, however, no evidence of arrhythmogenicity in 
either group during this procedure.
Neutralizing efficiency of the incubated products
The scorpion venom incubated with the equine 
antivenom (100 µl) increased the mean arterial pressure 
53.8% at the fourth minute in the treated rats (Figure 
4A). Additionally, it had no neutralizing potencies upon 
the negative chronotropic changes since the value of the 
heart rate had transient decrease to 25.97% below the 
initial value five minutes after the intravascular injection 
(Figure 4B). No significant alterations were observed 
in the arterial pressure and the heart rate following 
incubation with the camelid antivenom.
 
 
 
Time (min) Control Camelid AV (100 µl) Equine AV (100 µl) 
0 67.33±2.21a 73.33±4.56 76.24±6.34 
5 55.12±3.13 60.12±3.94 86.12±7.23* 
10 52.67±1.93 62.34±5.12 108.67±8.63* 
15 63.12±4.24 68.43±4.17 94.67±6.37* 
20 59.33±3.76 66.67±3.29 81.33±5.78* 
 
Table 1. Mean arterial pressure changes upon time after camelid and equine antivenom injection in rats
a Values are the mean±SD of the mean arterial pressure (mm Hg) in each group (n=6) before and after intravenous injection of the camelid and 
equine antivenoms
* Significantly different from the control group, ANOVA test, P-value<0.05 
 
  
Figure 2. The effects of escalating doses of camelid antivenom 
(10, 50, and 100 µl) on inotropic responses in anesthetized rats.* 
P-value<0.01, significantly different from the venom injection, 
analyzed with repeated measures ANOVA test
 
  
Figure 3. Arrhythmogenic evaluation of the camelid and equine 
antivenom in rats. There was no evidence of arrhythmogenicity in 
either trace upon time
 
Figure 4. Inotropic and chronotropic effects (Figures 4A and 4B) of 
H. lepturus venom (400 µg/rat) incubated with equine (Eqi AV) or 
camelid antivenoms (Cam AV) with an equal volume (100 µl; IV)
*P-value<0.01, significantly different from the equine antivenom
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Discussion
Scorpions are considered a threat to farmers, villagers, 
and passengers, especially in dry and hot environments. 
It is estimated that approximately 2.3 billion people 
are prone to scorpion bite (14). However, the number 
of envenomations is greater than one million annually 
(15). It should be pointed out that Iran has a large fauna 
with at least 52 species of this animal among Middle 
East countries (16).
Prior studies have noted the importance of the careful 
evaluation of the hemodynamic changes, including 
myocardial damage, pulmonary edema, and occasional 
hypertension, due to scorpion envenomation, especially 
among infants (17).                          
Cardiovascular deterioration caused by 
envenomation necessitates equine antivenom injection 
and symptomatic therapy as early as possible. Recently, 
camelid antivenom has been used due to its lower 
immunogenicity, more thermo-stability, and less 
potency to induce anaphylactic shock (18). 
It must be taken into account that H. lepturus, 
which belongs to the Scorpionidae family, has lower 
cardiogenic effects on rats compared to other venomous 
scorpions like Tityus serrulatus (1200 µg/kg versus 200 
µg/kg) (11, 19-20). 
Furthermore, this study found that more attempts 
have been carried out by Razi Institute antivenom to 
eliminate the impurities of the equine antivenom (21).  
Further analysis showed that pretreatment with 
the camelid antivenom (100 µl) could significantly 
neutralize the transient arterial pressure elevation 
induced by H. lepturus venom (Figure 2). However, it 
had no neutralizing potency when injected soon after 
venom instillation (data not shown). According to our 
experimental results, it seems that contrary to the 
equine antivenom, heavy chain antibodies in the camelid 
product make it a suitable remedy due to its safety, high 
affinity, and finally cardiovascular neutralizing potency 
(22-25). More precautions should be taken to inject the 
equine antivenom intravenously since it can elevate 
mean arterial pressure by itself in a short time (Table 
1). Unlike other antivenoms, the definite causes of the 
hypertensive property of this product are unknown and 
requires more investigation (26, 27).                                                                       
The present experiment was in line with the previous 
studies showing no neutralizing effects following 
animal pretreatment with the equine antivenom against 
cardiovascular changes caused by the venomous 
animals (3, 4, 28). Furthermore, the previous report 
has also shown the venom neutralizing capacity of the 
camelid antivenom against hemodynamic deterioration 
following Hottentota saulcyi envenomation (29).
Conclusion
There is no consensus among scientists regarding 
the neutralizing potency of equine antivenom on 
hemodynamic changes following envenomation in 
animals and humans. Returning to the hemodynamic 
results obtained in this study, it is evident that Razi 
Institute antivenom should be slowly infused in 
envenomed rats owing to its own tendency to raise mean 
arterial pressure. Furthermore, the camelid antivenom 
could be introduced as a novel therapy counteracting 
the hemodynamic dramatic changes.
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